Skip to Content

Dasabuvir, ombitasvir and ritonavir Approval Status

  • FDA approved: No
  • Generic name: dasabuvir, ombitasvir and ritonavir
  • Company: AbbVie Inc.
  • Treatment for: Hepatitis C

Dasabuvir, ombitasvir and ritonavir is an oral, direct-acting antiviral (DAA) fixed-dose combination in development for the treatment of Hepatitis C.

Development Status and FDA Approval Process for dasabuvir, ombitasvir and ritonavir

Apr 22, 2014AbbVie Submits NDA to FDA for Oral, Interferon-Free Therapy for the Treatment of Hepatitis C

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.